DJ-1 administration exerts cardioprotection in a mouse model of acute myocardial infarction

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Cardiovascular diseases, and particularly acute myocardial infarction (MI), are the most common causes of death worldwide. Infarct size is the major predictor of clinical outcomes in MI. The Parkinson’s disease associated protein, DJ-1 (also known as PARK7), is a multifunctional protein with chaperone, redox sensing and mitochondrial homeostasis activities. Previously, we provided the evidence for a central role of endogenous DJ-1 in the cardioprotection of post-conditioning. In the present study, we tested the hypothesis that systemic administration of recombinant DJ-1 exerts cardioprotective effects in a mouse model of MI and also explored the associated transcriptional response. We report a significant treatment-induced reduction in infarct size, leukocyte infiltration, apoptosis and oxidative stress. Effects potentially mediated by G-protein-coupled receptor signaling and modulation of the immune response. Collectively, our results indicate a protective role for the exogenously administrated DJ-1 upon MI, and provide the first line of evidence for an extracellular activity of DJ-1 regulating cardiac injury in vivo.

Cite

CITATION STYLE

APA

Gallinat, A., Mendieta, G., Vilahur, G., Padró, T., & Badimon, L. (2022). DJ-1 administration exerts cardioprotection in a mouse model of acute myocardial infarction. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.1002755

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free